vaistinė Multifarma - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 48,522 | 47,705 | 48,168 | 48,702 | 51,487 | 51,742 | 59,739 | 71,796 |
| Profit before tax | 2,872 | 506 | 2,368 | 666 | 501 | 415 | 1,084 | 1,497 |
| Net profit | 2,711 | 463 | 2,232 | 615 | 459 | 377 | 1,013 | 1,386 |
| Equity | 16,733 | 17,030 | 19,265 | 19,881 | 20,340 | 20,716 | 21,729 | 23,115 |
| Liabilities | 7,381 | 7,289 | 7,244 | 8,526 | 12,974 | 18,752 | 17,749 | 15,519 |
| Non-current assets | 6,869 | 6,708 | 6,483 | 5,945 | 5,481 | 5,133 | 4,785 | 5,013 |
| Current assets | 17,245 | 17,611 | 20,026 | 22,462 | 22,994 | 25,864 | 26,691 | 26,087 |
| Total assets | 24,114 | 24,319 | 26,509 | 28,407 | 28,475 | 30,997 | 31,476 | 31,100 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 5,827 | 6,607 | 8,398 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +2.4% | -1.7% | +1.0% | +1.1% | +5.7% | +0.5% | +15.5% | +20.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 11.2% | 1.9% | 8.4% | 2.2% | 1.6% | 1.2% | 3.2% | 4.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 16.2% | 2.7% | 11.6% | 3.1% | 2.3% | 1.8% | 4.7% | 6.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 5.6% | 1.0% | 4.6% | 1.3% | 0.9% | 0.7% | 1.7% | 1.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.9% | 1.1% | 4.9% | 1.4% | 1.0% | 0.8% | 1.8% | 2.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | 0.9 | 0.8 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 16,174 | 15,902 | 16,056 | 16,234 | 17,162 | 17,247 | 19,913 | 22,091 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
vaistinė Multifarma - Social security debts
The company had no debts to Sodra
vaistinė Multifarma - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Multifarma, UAB (code 179757667) is a Private Limited Liability Company engaged in the retail sale of pharmaceutical products. In 2025, the company generated revenue of €71.8K and net profit of €1.4K, with a profit margin of 1.9%. Revenue increased by 20.2% year on year, and by 38.8% over two years, showing steady growth from €51.7K in 2023 to €59.7K in 2024 and €71.8K in 2025. Net profit also improved over the same period, rising from €377 in 2023 to €1.0K in 2024 and €1.4K in 2025. The balance sheet remained stable, with total assets of €31.1K in 2025, equity of €23.1K and liabilities of €15.5K. The equity ratio stood at 74.3%, debt to equity at 0.67, ROE at 6.0%, ROA at 4.5%, and asset turnover at 2.31x. Revenue per employee was €23.9K, while profit per employee was €462, indicating modest but positive profitability and efficient use of assets.